Lacosamide for bipolar disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Jan 2026: Trial started, NCT07412132
  2. 17 Feb 2026: Trial registered, NCT07412132

The trials

NCT07412132: Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

State
Under way
Phase
Phase 3
People
40 planned
Started
9 Jan 2026
Primary completion
Jan 2027
Arms
Active Group
Results
None posted
  1. 9 Jan 2026: Trial started
  2. 17 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Motpoly, Vimpat.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.